Edgewise Therapeutics, Inc.
Developing novel therapeutics for rare and serious muscle disorders.
EWTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US28036F1057
- LEI:
- Country:
- United States of America
- Address:
- 1715 38TH ST, 80301 BOULDER
- Website:
- https://edgewisetx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare and serious muscle disorders. Founded in 2017, the company leverages its specialized expertise and singular focus on muscle science to create precision medicines for debilitating skeletal and cardiac muscle diseases, such as muscular dystrophies. Edgewise is committed to addressing significant unmet medical needs for patients with these conditions through its innovative scientific approach.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Edgewise Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Edgewise Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Edgewise Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
